Pages that link to "Q44308357"

The following pages link to Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells (Q44308357):

Displaying 33 items.

• Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile (Q28294205) (← links)
• BCR/ABL induces chromosomal instability after genotoxic stress and alters the cell death threshold (Q28704493) (← links)
• BCR-ABL stimulates mutagenic homologous DNA double-strand break repair via the DNA-end-processing factor CtIP. (Q33727572) (← links)
• Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells (Q33784347) (← links)
• BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells (Q33796384) (← links)
• Taking a Bad Turn: Compromised DNA Damage Response in Leukemia (Q33855938) (← links)
• Chronic myeloid leukaemia as a model of disease evolution in human cancer (Q34631354) (← links)
• Monozygotic twins discordant for constitutive BRCA1 promoter methylation, childhood cancer and secondary cancer (Q35897276) (← links)
• Chronic myelogenous leukemia stem and progenitor cells demonstrate chromosomal instability related to repeated breakage-fusion-bridge cycles mediated by increased nonhomologous end joining (Q36058572) (← links)
• Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice (Q36488976) (← links)
• Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia (Q36612343) (← links)
• Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation. (Q36695924) (← links)
• Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia (Q36883073) (← links)
• Signaling networks associated with BCR-ABL-dependent transformation (Q37428655) (← links)
• BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia (Q37743173) (← links)
• Fanconi anaemia: from a monogenic disease to sporadic cancer (Q37865169) (← links)
• Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation (Q38931383) (← links)
• DNA damage response and hematological malignancy (Q39218048) (← links)
• Expression of the p210BCR-ABL oncoprotein drives centrosomal hypertrophy and clonal evolution in human U937 cells (Q40114134) (← links)
• BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint (Q40572217) (← links)
• Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms (Q41217822) (← links)
• Methylation patterns in CD34 positive chronic myeloid leukemia blast crisis cells (Q42765023) (← links)
• Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia (Q44500993) (← links)
• Genomic instability is a principle pathologic feature of FLT3 ITD kinase activity in acute myeloid leukemia leading to clonal evolution and disease progression (Q46406409) (← links)
• BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. (Q53218157) (← links)
• Genomic instability in chronic myeloid leukemia: targets for therapy? (Q53272675) (← links)
• T315I mutation of BCR-ABL1 into human Philadelphia chromosome-positive leukemia cell lines by homologous recombination using the CRISPR/Cas9 system. (Q55517432) (← links)
• Unraveling the role of FANCD2 in chronic myeloid leukemia (Q57952410) (← links)
• Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML) (Q58794449) (← links)
• TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair (Q64084873) (← links)
• PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions (Q89187128) (← links)
• Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update (Q91812801) (← links)
• SNPs in lncRNA Regions and Breast Cancer Risk (Q97883645) (← links)